Last activity: 18.05.2023
Categories: TechnologyPlatformHuman
OncoResponse studies the immune systems of patients who are “elite responders” to cancer immunotherapies in order to develop new treatments for a broader array of cancer patients.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $153.1M
Founded date: 2016

Investors 6

Funding Rounds 7

31.03.2021Series C$40.6M-
11.09.2018Series B$40M-
09.03.2017Series A$22.5M-
10.10.2016-$3.5MHelsinn In...
10.10.2016Series A$7M-
29.05.2016Series A$12.5M-

Mentions in press and media 25

18.05.2023OncoResponse lands $27M to advance development of antibody-b...— Seattle biotech company OncoResponse landed $27 million to advance the development and testing of ...geekwire.c...
07.07.2021ONCORESPONSE APPOINTS SEAN McCARTHY TO BOARD OF DIRECTORSSEATTLE, Washington – July 7, 2021 – OncoResponse, a biotechnology company harnessing the power...3bfuturehe...
31.03.2021Seattle biotech OncoResponse raises $40.6M to create antibod...Clifford Stocks. (OncoResponse Photo) New funding: OncoResponse raised a $40.6M Series C investment...geekwire.c...
31.03.2021OncoResponse Raises $40.6 Million Series C Financing– New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies – Adds Magnet...3bfuturehe...
31.03.2021OncoResponse Raises $40.6 Million Series C Financing- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnet...marketscre...
14.04.2020OncoResponse Appoints Robert Lechleider, MD as Chief Medical...SEATTLE, WA / ACCESSWIRE / April 14, 2020 / OncoResponse, a biotechnology company developing human ...3bfuturehe...
18.06.2019Houston’s Startups Are Now an Entrepreneurial PowerhouseHouston is the most ethnically diverse metropolitan area in the U.S and is expected to become the th...startupgen...
12.09.2018Term Sheet — Wednesday, September 12REBOOT REPRESENTATION Good morning, Term Sheet readers. Paid Content Securing the enterprise witho...fortune.co...
11.09.2018OncoResponse raises $40M to start clinical trials of antibod...(Bigstock Photo) OncoResponse, a Seattle biotech company creating antibody-based treatments for can...geekwire.c...
11.09.2018OncoResponse Raises $40M in Series B FinancingOncoResponse, a Seattle, WA-based immunotherapy company developing a portfolio of novel antibodies t...finsmes.co...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In